Innate immunity to enteric virus infection by IFN?-stimulated-gene expression
Innate immunity to enteric virus infection by IFN?-stimulated-gene expression
批准号:
9918845
负责人:
Timothy J. Nice
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-05-09 至 2022-04-30
关键词:
AgeAntibioticsAntiviral AgentsAntiviral ResponseBacteriaBiologyCandidate Disease GeneCell Culture TechniquesCellsCellular TropismChildhoodCoculture TechniquesDevelopmentDiarrheaEnteralEpithelialEpithelial CellsEpitheliumEquilibriumFaceGastroenteritisGene ExpressionGene Expression ProfilingGenesGenetic TranscriptionGoalsImmuneImmunityImmunotherapyIn VitroInfectionInterferonsIntestinesKnock-outKnockout MiceModelingMucous MembraneMusNatural ImmunityNorovirusReceptor GeneRecombinant InterferonRegulationRegulatory PathwayRoleRotavirusRotavirus InfectionsSignal TransductionSpecificitySurfaceSystemTestingTherapeuticViralVirusVirus DiseasesWorkantiviral immunitybacteriomecell typecytokinedrug developmentglobal healthin vivointestinal epitheliummacrophagemicrobiomemicrobiome alterationmouse modelnovelpreventprogramsreceptorresponsetooltranscriptome
中文摘要
项目摘要 - 通过 IFNλ 刺激的基因表达对肠道病毒感染的先天免疫
肠道和其他粘膜表面的抗病毒免疫面临着独特的挑战:清除病毒
感染,同时保持细菌微生物组的屏障功能和耐受性。为了维持这种平衡,
对粘膜表面具有特异性的免疫机制已经进化。干扰素 lambda (IFNλ) 刺激
肠上皮细胞(IEC)的抗病毒反应,是肠道免疫的重要组成部分
诺如病毒(MNV)和轮状病毒(MRV)感染的小鼠模型; IFNλ 控制这些的要求
肠道病毒感染使其与其他干扰素类型不同。此外,细菌微生物组
以 IFNλ 受体 (IFNLR) 依赖性方式促进 MNV 感染,表明微生物组
改变 IFNλ 刺激的抗病毒反应。该提案旨在缩小我们理解上的差距
关于 IFNλ 独特的转录程序,细菌微生物组对这些转录程序的影响
转录程序,以及病毒控制所需的特定干扰素刺激基因(ISG)。具体
目标 1 将全面表征 IEC 中的转录反应并确定必要的基因
用于轮状病毒感染的细胞内在控制。具体目标 2 将使用新型肠道巨噬细胞和 IEC 联合
培养系统以确定 IFNλ 刺激细胞外 MNV 清除的机制。具体目标
图3将确定共生微生物组在调节IFNλ刺激的抗病毒反应中的作用。
这项工作的长期目标是发现 IFN 生物学及其在细胞中的调控的新方面。
肠道,这将有助于抗病毒药物和免疫疗法的合理开发。
英文摘要
Project Summary - Innate immunity to enteric virus infection by IFNλ-stimulated-gene expression
Antiviral immunity in the intestine and other mucosal surfaces faces a distinct challenge: clearance of viral
infection while maintaining barrier function and tolerance of the bacterial microbiome. To maintain this balance,
immune mechanisms with specificity to mucosal surfaces have evolved. Interferon lambda (IFNλ) stimulates
antiviral responses in intestinal epithelial cells (IECs) and is a critical component of intestinal immunity in
mouse models of norovirus (MNV) and rotavirus (MRV) infection; this requirement for IFNλ in control of these
enteric virus infections distinguishes it from other interferon types. Additionally, the bacterial microbiome
promotes MNV infection in an IFNλ receptor- (IFNLR) dependent manner, suggesting that the microbiome
alters the IFNλ-stimulated antiviral response. This proposal aims to close the gap in our understanding
regarding transcriptional programs unique to IFNλ, the effect of the bacterial microbiome on those
transcriptional programs, and the specific interferon stimulated genes (ISGs) required for viral control. Specific
Aim 1 will comprehensively characterize the transcriptional response in IECs and identify the genes necessary
for cell-intrinsic control of rotavirus infection. Specific Aim 2 will use novel intestinal macrophage and IEC co-
culture system to identify mechanisms by which IFNλ stimulates cell-extrinsic clearance of MNV. Specific Aim
3 will determine the role of the commensal microbiome in regulation of IFNλ-stimulated antiviral responses.
The long-term goal of this work is to discover novel aspects of IFN biology and its regulation in the
intestine that will aid in rational development of antivirals and immunotherapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innate immunity to enteric virus infection by IFN-lambda stimulated-gene expression
-
批准号:10708150
-
项目类别:
-
资助金额:$46.2万
-
财政年份:2017
-
负责人:Timothy J. Nice
-
依托单位:
Innate immunity to enteric virus infection by IFN-lambda stimulated-gene expression
-
批准号:10583367
-
项目类别:
-
资助金额:$45.35万
-
财政年份:2017
-
负责人:Timothy J. Nice
-
依托单位:
海外基金